Recent Advancement of Pyrazole Scaffold Based Neuroprotective Agents: A Review

CNS Neurol Disord Drug Targets. 2022;21(10):940-951. doi: 10.2174/1871527320666210602152308.

Abstract

As a source of therapeutic agents, heterocyclic nitrogen-containing compounds and their derivatives are still interesting and essential. Pyrazole, a five-member heteroaromatic ring with two nitrogen atoms, has a major impact in chemical industries as well as pharmaceutical industries. Due to its wide range of biological activities against various diseases, it has been identified as a biologically important heterocyclic scaffold. The treatment of neurological disorders has always been a difficult task in both the past and present. Therefore, identifying therapeutically effective molecules for neurological conditions remains an open challenge in biomedical research and development. For developing novel entities as neuroprotective agents, recently, pyrazole scaffold has attracted medicinal chemists worldwide. The major focus of research in this area is discovering novel molecules as neuroprotective agents with minimal adverse effects and better effectiveness in improving the neurological condition. This review mainly covers recent developments in the neuropharmacological role of pyrazole incorporated compounds, including their structural-activity relationship (SAR), which also further includes IC50 values (in mM as well as in μM), recent patents, and a brief history as neuroprotective agents.

Keywords: Pyrazole; heteroaromatic ring; heterocycles; neurological disorder; neuroprotective agents; structural-activity relationship.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Neuroprotective Agents* / pharmacology
  • Neuroprotective Agents* / therapeutic use
  • Nitrogen
  • Pyrazoles / pharmacology
  • Pyrazoles / therapeutic use
  • Structure-Activity Relationship

Substances

  • Antineoplastic Agents
  • Neuroprotective Agents
  • Pyrazoles
  • Nitrogen